Our finding is in agreement with the study by Terai et al.60, showing that CRISPR/Cas9-mediated knockout of ufmylation genes in lung cancer cells specifically activated the IRE1α-Xbp1 branch. The gene discussed is XBP1; the disease is lung carcinoma.